Explore AI Agent Skills & Claude Prompts

Write comprehensive clinical reports including case reports (CARE guidelines), diagnostic reports (radiology/pathology/lab), clinical trial reports (ICH-E3, SAE, CSR), and patient documentation (SOAP, H&P, discharge summaries). Full support with templates, regulatory compliance (HIPAA, FDA, ICH-GCP), and validation tools.

figure-pipeline

Five-step figure generation pipeline inspired by PaperVizAgent (Google Research, 2026). Orchestrates Retriever → Planner → Stylist → Visualizer → Critic stages for publication-quality scientific figures. Retrieves reference figures from literature, plans layout and composition, applies journal-specific styling, generates the figure, then critiques and refines. Use when the user needs high-quality figures for papers/presentations and wants a more deliberate, reference-driven approach than direct code generation. Especially useful for multi-panel figures and complex data visualizations.

tooluniverse-precision-oncology

Provide actionable treatment recommendations for cancer patients based on molecular profile. Interprets tumor mutations, identifies FDA-approved therapies, finds resistance mechanisms, matches clinical trials. Use when oncologist asks about treatment options for specific mutations (EGFR, KRAS, BRAF, etc.), therapy resistance, or clinical trial eligibility.

peer-review

Conduct thorough academic peer reviews with structured feedback using load_pdf and arxiv_to_prompt

tooluniverse-rare-disease-diagnosis

Provide differential diagnosis for patients with suspected rare diseases based on phenotype and genetic data. Matches symptoms to HPO terms, identifies candidate diseases from Orphanet/OMIM, prioritizes genes for testing, interprets variants of uncertain significance. Use when clinician asks about rare disease diagnosis, unexplained phenotypes, or genetic testing interpretation.

cjk-viz

CJK (中日韩) 字体检测与 matplotlib 配置。任何涉及中文标签、标题、图例的可视化任务启动前必须先执行本 skill 的字体检测流程，确保不会出现方块乱码。适用于 matplotlib / seaborn / plotly 静态导出等场景。

tooluniverse-cancer-variant-interpretation

Provide comprehensive clinical interpretation of somatic mutations in cancer. Given a gene symbol + variant (e.g., EGFR L858R, BRAF V600E) and optional cancer type, performs multi-database analysis covering clinical evidence (CIViC), mutation prevalence (cBioPortal), therapeutic associations (OpenTargets, ChEMBL, FDA), resistance mechanisms, clinical trials, prognostic impact, and pathway context. Generates an evidence-graded markdown report with actionable recommendations for precision oncology. Use when oncologists, molecular tumor boards, or researchers ask about treatment options for specific cancer mutations, resistance mechanisms, or clinical trial matching.

export-pptx

Export research project findings to a presentation (.pptx) with key findings, figures, and conclusions. Use when user says "导出 PPT", "/export pptx", "做个汇报", "生成 PPT", "export to PowerPoint", "make a presentation from results", or wants slides from project results. Builds on pptx-generation skill.

tooluniverse-adverse-event-detection

Detect and analyze adverse drug event signals using FDA FAERS data, drug labels, disproportionality analysis (PRR, ROR, IC), and biomedical evidence. Generates quantitative safety signal scores (0-100) with evidence grading. Use for post-market surveillance, pharmacovigilance, drug safety assessment, adverse event investigation, and regulatory decision support.

export-latex

Export research project findings to a LaTeX manuscript draft with figures, references, and methods. Supports Nature, Cell, Lancet, and generic article formats. Use when user says "导出 LaTeX", "/export latex", "写论文初稿", "export to LaTeX", "generate manuscript", or wants a paper draft from project results. Builds on venue-templates skill.

tooluniverse-immunotherapy-response-prediction

Predict patient response to immune checkpoint inhibitors (ICIs) using multi-biomarker integration. Given a cancer type, somatic mutations, and optional biomarkers (TMB, PD-L1, MSI status), performs systematic analysis across 11 phases covering TMB classification, neoantigen burden estimation, MSI/MMR assessment, PD-L1 evaluation, immune microenvironment profiling, mutation-based resistance/sensitivity prediction, clinical evidence retrieval, and multi-biomarker score integration. Generates a quantitative ICI Response Score (0-100), response likelihood tier, specific ICI drug recommendations with evidence, resistance risk factors, and a monitoring plan. Use when oncologists ask about immunotherapy eligibility, checkpoint inhibitor selection, or biomarker-guided ICI treatment decisions.

tooluniverse-precision-medicine-stratification

Comprehensive patient stratification for precision medicine by integrating genomic, clinical, and therapeutic data. Given a disease/condition, genomic data (germline variants, somatic mutations, expression), and optional clinical parameters, performs multi-phase analysis across 9 phases covering disease disambiguation, genetic risk assessment, disease-specific molecular stratification, pharmacogenomic profiling, comorbidity/DDI risk, pathway analysis, clinical evidence and guideline mapping, clinical trial matching, and integrated outcome prediction. Generates a quantitative Precision Medicine Risk Score (0-100) with risk tier assignment (Low/Intermediate/High/Very High), treatment algorithm (1st/2nd/3rd line), pharmacogenomic guidance, clinical trial matches, and monitoring plan. Use when clinicians ask about patient risk stratification, treatment selection, prognosis prediction, or personalized therapeutic strategy across cancer, metabolic, cardiovascular, neurological, or rare diseases.